Advertisement
Screener

DMK PHARMACEUTICALS CORPORATION Proceeds from Warrant Exercises

DMK PHARMACEUTICALS CORPORATION Proceeds from Warrant Exercises

DMK PHARMACEUTICALS CORPORATION reported Proceeds from Warrant Exercises of $790 for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-14.

Discontinued › Cash Flow › Financing Activities

us-gaap:ProceedsFromWarrantExercises · last filed 2023-11-14

  • DMK PHARMACEUTICALS CORPORATION proceeds from warrant exercises for the quarter ending 2023-09-30 was $40.00.
  • DMK PHARMACEUTICALS CORPORATION proceeds from warrant exercises for the quarter ending 2021-12-31 was $0.00.
  • DMK PHARMACEUTICALS CORPORATION proceeds from warrant exercises for the quarter ending 2021-09-30 was $0.00.
  • DMK PHARMACEUTICALS CORPORATION proceeds from warrant exercises for the quarter ending 2021-06-30 was $0.00.
  • DMK PHARMACEUTICALS CORPORATION proceeds from warrant exercises for fiscal 2021 was $5.85M.
  • DMK PHARMACEUTICALS CORPORATION proceeds from warrant exercises for fiscal 2017 was $16.77M, a 9331.18% increase from fiscal 2016.
  • DMK PHARMACEUTICALS CORPORATION proceeds from warrant exercises for fiscal 2016 was $177.78K, a 135.19% increase from fiscal 2015.
  • DMK PHARMACEUTICALS CORPORATION proceeds from warrant exercises for fiscal 2015 was $75.59K.
Period endProceeds from Warrant Exercises 0 monthProceeds from Warrant Exercises 2 monthProceeds from Warrant Exercises 3 monthProceeds from Warrant Exercises 6 monthProceeds from Warrant Exercises 9 monthProceeds from Warrant Exercises 12 month
2023-09-30$40.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14
$790.00
10-Q · filed 2023-11-14
2023-06-30$750.00
10-Q · filed 2023-08-21
2021-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16
$0.00
derived: sum of 2 quarters · filed 2023-03-16
$0.00
derived: sum of 3 quarters · filed 2023-03-16
$5.85M
10-K · filed 2023-03-16
2021-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14
$0.00
derived: sum of 2 quarters · filed 2022-11-14
$5.85M
10-Q · filed 2022-11-14
2021-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10
$5.85M
10-Q · filed 2022-08-10
2021-03-31$5.85M
10-Q · filed 2022-05-16
2021-02-28$5.85M
10-Q · filed 2021-11-22
2021-02-02$5.85M
10-Q · filed 2022-05-16
2017-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-15
$16.45M
derived: sum of 2 quarters · filed 2019-03-15
$16.77M
10-K · filed 2019-03-15
2017-09-30$16.45M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09
$16.77M
10-Q · filed 2018-11-09
2017-06-30$321.11K
10-Q · filed 2018-08-09
2016-12-31-$1.00
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16
-$1.00
derived: sum of 2 quarters · filed 2018-03-16
$88.89K
derived: sum of 3 quarters · filed 2018-03-16
$177.78K
10-K · filed 2018-03-16
2016-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14
$88.89K
derived: sum of 2 quarters · filed 2017-11-14
$177.78K
10-Q · filed 2017-11-14
$177.78K
derived: sum of 4 quarters · filed 2017-11-14
2016-06-30$88.89K
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14
$177.78K
10-Q · filed 2017-08-14
$177.78K
derived: sum of 3 quarters · filed 2017-08-14
$177.78K
derived: sum of 4 quarters · filed 2017-08-14
2016-03-31$88.89K
10-Q · filed 2017-05-12
$88.89K
derived: sum of 2 quarters · filed 2017-05-12
$88.89K
derived: sum of 3 quarters · filed 2017-05-12
$88.89K
derived: sum of 4 quarters · filed 2017-05-12
2015-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-30
$0.00
derived: sum of 2 quarters · filed 2017-03-30
$0.00
derived: sum of 3 quarters · filed 2017-03-30
$75.59K
10-K · filed 2017-03-30
2015-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14
$0.00
derived: sum of 2 quarters · filed 2016-11-14
$75.59K
10-Q · filed 2016-11-14
2015-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-15
$75.59K
10-Q · filed 2016-08-15
2015-03-31$75.59K
10-Q · filed 2016-05-13
2014-09-30$170.00K
10-Q · filed 2014-11-14
$170.00K
10-Q · filed 2015-11-09